Tefferi A - Search Results

1

Aetiology and outcomes of secondary myelofibrosis occurring in the context of inherited platelet disorders: A single institutional study of four patients.

Saliba AN, Ferrer A, Gangat N, Pruthi RK, Tefferi A, Higgins A, Bezerra ED, Buglioni A, Salama ME, Klee EW, Pinto E Vairo F, Mangaonkar A, Majerus J, Chen D, Patnaik MM. Saliba AN, et al. Among authors: tefferi a. Br J Haematol. 2020 Sep;190(5):e316-e320. doi: 10.1111/bjh.16897. Epub 2020 Jun 22. Br J Haematol. 2020. PMID: 32567678 Free article. No abstract available.

2

Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia.

Tefferi A, Schad CR, Pruthi RK, Ahmann GJ, Spurbeck JL, Dewald GW. Tefferi A, et al. Cancer Genet Cytogenet. 1995 Aug;83(1):61-4. doi: 10.1016/0165-4608(95)00036-4. Cancer Genet Cytogenet. 1995. PMID: 7656207

3

Pernicious anemia revisited.

Pruthi RK, Tefferi A. Pruthi RK, et al. Among authors: tefferi a. Mayo Clin Proc. 1994 Feb;69(2):144-50. doi: 10.1016/s0025-6196(12)61041-6. Mayo Clin Proc. 1994. PMID: 8309266 Review.

4

The biochemical basis of cobalamin deficiency.

Tefferi A, Pruthi RK. Tefferi A, et al. Mayo Clin Proc. 1994 Feb;69(2):181-6. doi: 10.1016/s0025-6196(12)61046-5. Mayo Clin Proc. 1994. PMID: 8309270 Review.

5

2-Chlorodeoxyadenosine treatment after splenectomy in patients who have myelofibrosis with myeloid metaplasia.

Tefferi A, Silverstein MN, Li CY. Tefferi A, et al. Br J Haematol. 1997 Nov;99(2):352-7. doi: 10.1046/j.1365-2141.1997.3843198.x. Br J Haematol. 1997. PMID: 9375753 Free article.

6

Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.

Elliott MA, Chen MG, Silverstein MN, Tefferi A. Elliott MA, et al. Among authors: tefferi a. Br J Haematol. 1998 Nov;103(2):505-11. doi: 10.1046/j.1365-2141.1998.00998.x. Br J Haematol. 1998. PMID: 9827926 Free article.

7

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Yoon SY, Li CY, Mesa RA, Tefferi A. Yoon SY, et al. Among authors: tefferi a. Br J Haematol. 1999 Sep;106(3):682-8. doi: 10.1046/j.1365-2141.1999.01598.x. Br J Haematol. 1999. PMID: 10468856 Free article.

8

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.

Tefferi A, Mesa RA, Schroeder G, Hanson CA, Li CY, Dewald GW. Tefferi A, et al. Br J Haematol. 2001 Jun;113(3):763-71. doi: 10.1046/j.1365-2141.2001.02796.x. Br J Haematol. 2001. PMID: 11380468 Free article.

9

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC. Mesa RA, et al. Among authors: tefferi a. Br J Haematol. 2001 Jul;114(1):111-3. doi: 10.1046/j.1365-2141.2001.02883.x. Br J Haematol. 2001. PMID: 11472354 Free article. Clinical Trial.

10

Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.

Tefferi A, Meyer RG, Wyatt WA, Dewald GW. Tefferi A, et al. Br J Haematol. 2001 Nov;115(2):316-9. doi: 10.1046/j.1365-2141.2001.03131.x. Br J Haematol. 2001. PMID: 11703327 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,184 results

Search Page

Filters